← back to search

Lu Shen

Nanchang University · CN
Area of research
Pharmacology · Cancer Research
Research interest
Research interests include Pharmacogenetics and Drug Metabolism, MicroRNA in disease regulation, Genetic Associations and Epidemiology, and Lung Cancer Treatments and Mutations.
h-index
28
citations
3,373
works
186
NIH funding
primary concept
email

Recent publications

Development of a Recombinant Outer Membrane Vesicles (OMVs)‐Based Vaccine Against <i>Helicobacter pylori</i> Infection in Mice
Journal of Extracellular Vesicles 2025cited by 15position: middledoi
Adjuvants for <i>Helicobacter pylori</i> vaccines: Outer membrane vesicles provide an alternative strategy
Virulence 2024cited by 9position: middledoi
Refining antipsychotic treatment strategies in schizophrenia: discovery of genetic biomarkers for enhanced drug response prediction
Molecular Psychiatry 2024cited by 7position: middledoi
Coxsackievirus group B3 regulates ASS1-mediated metabolic reprogramming and promotes macrophage inflammatory polarization in viral myocarditis
Journal of Virology 2024cited by 6position: middledoi
168P Real-world clinicopathological characteristics and treatment patterns of esophageal cancer patients in China
Annals of Oncology 2023cited by 0position: lastdoi
Cytochrome P450 Enzymes and Drug Metabolism in Humans
International Journal of Molecular Sciences 2021cited by 939position: middledoi
A resident stromal cell population actively restrains innate immune response in the propagation phase of colitis pathogenesis in mice
Science Translational Medicine 2021cited by 38position: middledoi
The predictive prognostic values of CBFA2T3, STX3, DENR, EGLN1, FUT4, and PCDH7 in lung cancer
Annals of Translational Medicine 2021cited by 22position: middledoi
Evaluating Distribution and Prognostic Value of New Tumor-Infiltrating Lymphocytes in HCC Based on a scRNA-Seq Study With CIBERSORTx
Frontiers in Medicine 2020cited by 31position: middledoi
Genetic Association of Olanzapine Treatment Response in Han Chinese Schizophrenia Patients
Frontiers in Pharmacology 2019cited by 21position: middledoi
Association studies of genomic variants with treatment response to risperidone, clozapine, quetiapine and chlorpromazine in the Chinese Han population
The Pharmacogenomics Journal 2015cited by 44position: middledoi
Diabetes Mellitus, Prediabetes, and Incidence of Subclinical Myocardial Damage
Circulation 2014cited by 234position: middledoi
Feedback Regulations of miR-21 and MAPKs via Pdcd4 and Spry1 Are Involved in Arsenite-Induced Cell Malignant Transformation
PLoS ONE 2013cited by 33position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Shengying Qin · Shanghai Jiao Tong University4 papers (2015–2021)Mo Li · South China Agricultural University4 papers (2015–2021)Yinpan Shang · Nanchang University3 papers (2024–2025)Ziwei Tao · Nanchang University3 papers (2024–2025)Qiong Liu · Guangzhou University of Chinese Medicine3 papers (2024–2025)Cong Huai · Shanghai Jiao Tong University2 papers (2019–2021)Lin He · South China Normal University2 papers (2015–2021)Hanchi Zhang · Nanchang University2 papers (2024–2024)Xiaotian Huang · Central South University2 papers (2024–2024)Zhenghui Yi · Fudan University2 papers (2015–2019)Zhili Liu · Nanchang University2 papers (2024–2024)Huijuan Liu · Capital Medical University1 papers (2021–2021)Hongguang Wu · Nanchang University1 papers (2021–2021)Lou Zhong · Nantong University1 papers (2021–2021)Zhirong Rao · Nanchang University1 papers (2024–2024)Jinrong Ma · Nanchang University1 papers (2025–2025)Qinghe Xing · Fudan University1 papers (2015–2015)Dongfeng Shi · Chongqing University1 papers (2023–2023)Lixing Li · Technical University of Munich1 papers (2020–2020)Lingbing Zeng · Nanchang University1 papers (2024–2024)